Lymphocyte activation in the pathogenesis of psoriasis.
暂无分享,去创建一个
[1] S. Ziegler,et al. The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris. , 1997, The Journal of investigative dermatology.
[2] I. Eperon,et al. Selective amplification of T-cell receptor variable region species is demonstrable but not essential in early lesions of psoriasis vulgaris: analysis by anchored polymerase chain reaction and hypervariable region size spectratyping. , 1997, The Journal of investigative dermatology.
[3] M. Detmar,et al. Murine psoriasis-like disorder induced by naive CD4+ T cells , 1997, Nature Medicine.
[4] B. Nickoloff,et al. Dermal injection of immunocytes induces psoriasis. , 1996, The Journal of clinical investigation.
[5] D. Leung,et al. Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. , 1996, The Journal of investigative dermatology.
[6] T. Zollner,et al. Pulling the trigger on psoriasis , 1996, Nature.
[7] J. Travers,et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. , 1995, The Journal of clinical investigation.
[8] A. Menssen,et al. Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. , 1995, Journal of immunology.
[9] D. Carlo,et al. CD8+ T‐Cells in Psoriatic Lesions Preferentially Use T‐Cell Receptors Vβ3 and/or Vβ13.1 Genes , 1995 .
[10] J. Travers,et al. The role of superantigens in skin disease. , 1995, The Journal of investigative dermatology.
[11] B. Böhm,et al. T-Cell-Receptor Repertoire in Chronic Plaque-Stage Psoriasis Is Restricted and Lacks Enrichment of Superantigen-Associated Vβ Regions , 1995 .
[12] James G. Krueger,et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis , 1995, Nature Genetics.
[13] I. Jónsdóttir,et al. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? , 1995, Immunology today.
[14] L. Picker,et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production , 1995, The Journal of experimental medicine.
[15] A. Menssen,et al. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.
[16] D. Carlo,et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] H. Dvorak,et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis , 1994, The Journal of experimental medicine.
[18] A. Gottlieb,et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy , 1994, The Journal of experimental medicine.
[19] James T. Elder,et al. GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes. , 1993, The Journal of investigative dermatology.
[20] J. Garioch,et al. Restricted T‐cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque psoriasis , 1993, The British journal of dermatology.
[21] M. Yamamura,et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.
[22] J. Voorhees,et al. T-lymphocyte clones initiated from lesional psoriatic skin release growth factors that induce keratinocyte proliferation. , 1993, The Journal of investigative dermatology.
[23] J. Garioch,et al. Group A streptococcal antigen‐specific T lymphocytes in guttate psoriatic lesions , 1993, The British journal of dermatology.
[24] D. Leung,et al. A potential role for superantigens in the pathogenesis of psoriasis. , 1993, The Journal of investigative dermatology.
[25] W. Sterry,et al. Type I and type II psoriasis show a similar usage of T-cell receptor variable regions. , 1991, The Journal of investigative dermatology.
[26] V. Dixit,et al. Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction. , 1991, Journal of dermatological science.
[27] K. L. Johnson,et al. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. , 1990, Journal of immunology.
[28] B. Bernard,et al. Spreading of psoriatic plaques: alteration of epidermal differentiation precedes capillary leakiness and anomalies in vascular morphology. , 1990, The Journal of investigative dermatology.
[29] J. Voorhees,et al. Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. , 1990, Archives of dermatology.
[30] H. Valdimarsson,et al. Epidermal T lymphocytes and HLA‐DR expression in psoriasis , 1984, The British journal of dermatology.
[31] H. Valdimarsson,et al. T‐cell subpopulations in the blood and skin of patients with psoriasis , 1984, The British journal of dermatology.
[32] B. Benacerraf,et al. Studies on the specificity of the cellular infiltrate of delayed hypersensitivity reactions. , 1963, Journal of immunology.